Core Points - Hyper Bit Technologies Ltd. has successfully closed a non-brokered private placement of unsecured convertible debentures totaling $512,450.77, receiving gross proceeds of $435,583.15 after a 15% original issue discount [1][2]. Group 1: Financial Details - The debentures are non-interest bearing and will mature three months from the issuance date, with the option for conversion into units at a price of $0.30 per unit [2]. - Each unit consists of one common share and one warrant, with each warrant allowing the purchase of one common share at $0.40 for a period of 36 months [3]. - The company paid a finder fee of $4,462.50 in connection with the offering [4]. Group 2: Use of Proceeds - Proceeds from the offering will be used to order up to 75 ElphaPex DG2 miners and for general working capital purposes [5]. Group 3: Company Strategy - The financing is aimed at strengthening the company's financial position as it prepares to acquire Dogecoin Mining Technologies and transition into active mining operations [4]. - The company is focused on preparing infrastructure and securing next-generation mining equipment to scale operations efficiently [4]. Group 4: Company Overview - Hyper Bit Technologies Ltd. specializes in crypto mining operations and blockchain innovations, aiming to unlock value in the crypto ecosystem amid rising global interest in digital assets [7]. - The company is a member of the Blockchain Association of Canada and the American Blockchain & Cryptocurrency Association [7].

Core Insights - Aprea Therapeutics, Inc. has provided an update on the Phase 1 ACESOT-1051 study, showing promising results for its WEE1 inhibitor, APR-1051, in patients with advanced solid tumors [1][2][5] Study Results - At the 100 mg dose level of APR-1051, 3 out of 4 patients achieved stable disease according to RECIST v1.1 criteria [1][5][6] - Disease stabilization was observed in patients with tumors harboring mutations relevant to WEE1 kinase inhibition, specifically FBXW7, CCNE1, KRAS, and TP53 [5][6][11] - The trial is currently progressing to a higher dose level of 150 mg following successful results from the 100 mg cohort [5][6] Presentation and Data - Preliminary results from the ACESOT-1051 trial will be presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics [2][5] - The poster presentation will summarize updated data with a cutoff date of September 17, 2025 [2] Company Overview - Aprea Therapeutics focuses on developing innovative cancer therapies that target specific vulnerabilities in cancer cells while minimizing damage to healthy cells [7] - The company's clinical programs include APR-1051, an oral small-molecule inhibitor of WEE1 kinase, and ATRN-119, a macrocyclic small molecule ATR inhibitor [7]

Bunge Global SA (NYSE: BG ) has completed the Viterra merger after previous uncertainty around the deal. The transaction shifts focus to Bunge’s post-merger synergy implementation, being critical due to the high debt that the transaction addedI am an avid investor with a major focus on small cap companies with experience in investing in US, Canadian, and European markets. My investment philosophy to generating great returns on the stock market revolves around identifying mispriced securities by understandin ...

FUKUOKA, Japan, Oct. 24, 2025 (GLOBE NEWSWIRE) -- rYojbaba Co., Ltd. (Nasdaq: RYOJ) (“rYojbaba” or the “Company”), a Japanese labor consulting and health services company, announced a strategic partnership with China Zhongqing International Holdings Co., Ltd. (“Zhongqing International”) to implement the Company’s Free Labor Union Program for Japan’s Technical Intern Training and Specified Skilled Worker Programs. Japan’s Technical Intern Training and Specified Skilled Worker programs were originally designe ...

Core Insights - Snail Games' upcoming title, Rebel Engine, has seen a remarkable increase in daily Steam wishlists, surging over 72 times compared to the pre-festival period, contributing to a 46% overall increase in total wishlists ahead of its launch on November 6, 2025 [2][3] - The game features a collaboration with Hakos Baelz, a prominent member of hololive English, which has helped attract a new audience, evidenced by the release of a music video that is gaining traction globally [2][3] - Snail Games showcased Rebel Engine at TwitchCon, enhancing visibility alongside other titles and leveraging partnerships with influencers to strengthen audience engagement [3] Franchise Performance - The ARK franchise continues to perform well, with a recent update for ARK: Ultimate Survivor Edition that includes backward compatibility and enhanced support for the Nintendo Switch 2, which is projected to have 25 million units produced by March 2026 [4] - This update aims to provide a seamless gaming experience across current and next-generation hardware, reinforcing the franchise's accessibility [4] Indie Publishing Growth - Snail's indie publishing arm, Wandering Wizard, is gaining recognition with the management simulator Above the Snow, which has won a NYX Award and is nominated for Best Narrative at the 2026 Indie Game Awards [5] - The studio is set to present Above the Snow at the Poznań Game Arena, further expanding its reach and establishing strategic partnerships that align with the game's theme [5] Overall Strategy - Snail Games is capturing increasing attention from players, creators, and critics through its diverse publishing portfolio, cross-collaborations, and global showcases, reflecting a deliberate approach to growth and long-term engagement in the interactive entertainment sector [6]

LOWELL, Mass., Oct. 24, 2025 (GLOBE NEWSWIRE) -- MACOM Technology Solutions Holdings, Inc. (“MACOM”) (Nasdaq: MTSI) plans to announce financial results for its fourth quarter and fiscal year 2025 ended October 3, 2025, before market open on Thursday, November 6, 2025. In conjunction with the release, MACOM will conduct a conference call at 8:30 a.m. Eastern Time on Thursday, November 6, 2025, hosted by Mr. Stephen G. Daly, President and Chief Executive Officer, and Mr. John F. Kober, Senior Vice President a ...

MIAMI, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Defiance ETFs is proud to announce the launch of the Defiance Daily Target 2X Long AVAV ETF (AVXX), expanding its suite of single-stock leveraged ETFs designed for active traders seeking amplified exposure to innovative, high-growth companies. The newest addition, AVXX, is designed for traders who seek magnified, short-term bullish exposure to AeroVironment Inc. (AVAV). By seeking to deliver 200% of the daily percentage change in the share price of AVAV, the fund all ...

HOUSTON, Oct. 24, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that Founder and Chief Executive Officer, Pete O’Heeron, will present at the Bio-Europe 2025 conference taking place November 3-5, 2025, at the Vienna Congress and Convention Cente ...

Core Points - OptimumBank will celebrate its 25th anniversary by ringing the Opening Bell at the New York Stock Exchange on October 27, 2025 [1][2] - The event signifies the bank's growth from a small community bank to a billion-dollar institution, highlighting its commitment to community service [3] - OptimumBank has surpassed $1 billion in assets in 2025 and continues to rank among the best-performing financial institutions in South Florida [3][4] Company Overview - Founded in 2000 in Fort Lauderdale, Florida, OptimumBank has evolved from a single-branch startup to a significant independent bank in the region [3][5] - The bank focuses on personal, relationship-driven service while integrating technology to enhance customer experience [4] - OptimumBank offers a range of financial solutions including Business Banking, Business Lending, SBA Lending Solutions, Treasury Management, and Personal Banking [5]

AUSTIN, Texas, Oct. 24, 2025 (GLOBE NEWSWIRE) -- via IBN – NetworkNewsAudio announces the Audio Press Release (APR) titled “Gold Surges Past $4,200 as Investors Flock to Producers with Cash Flow,”featuring ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF).  To hear the NetworkNewsAudio version, visit https://nnw.fm/LNzU9 To read the original editorial, visit https://nnw.fm/utJ17 Within the junior space, speculative explorers have long outnumbered real operators. But the new paradigm is different: Companies with hig ...